CorMedix Inc.
CRMD
$8.13
-$0.05-0.61%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -32.68% | 175.33% | -87.09% | 447.52% | -3.95% |
| Total Depreciation and Amortization | -0.04% | 1.06% | 175.26% | 2,225.46% | 0.62% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -50.34% | -34.05% | 170.49% | -2,160.72% | -23.58% |
| Change in Net Operating Assets | 212.49% | -208.21% | 217.91% | -451.87% | 257.96% |
| Cash from Operations | 103.48% | -55.13% | 206.13% | 2.89% | 51.95% |
| Capital Expenditure | 23.05% | 57.62% | -240.08% | -2,007.50% | -140.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | 100.48% | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -100.00% | 4.76% | -81.62% | 195.04% | -10,812.43% |
| Cash from Investing | -118.92% | -10.07% | 101.13% | -1,341.32% | -10,265.13% |
| Total Debt Issued | -- | -- | -100.00% | -- | -- |
| Total Debt Repaid | -31.11% | 2.74% | -182.11% | -- | -- |
| Issuance of Common Stock | -80.07% | -74.47% | 248.17% | -98.41% | 1,073.93% |
| Repurchase of Common Stock | 48.31% | -4,802.49% | 44.54% | -87.89% | 75.76% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -16.09% | 90.74% | -1,895.61% | -- | -- |
| Cash from Financing | 41.55% | -756.06% | -100.94% | 80.83% | 1,266.21% |
| Foreign Exchange rate Adjustments | -- | -- | -533.33% | -70.00% | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 136.41% | -65.49% | 187.64% | -218.18% | 262.87% |